Sagent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has fifty-six approved drugs.
Summary for Sagent Pharms Inc
| US Patents: | 0 |
| Tradenames: | 48 |
| Ingredients: | 47 |
| NDAs: | 56 |
Drugs and US Patents for Sagent Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202462-001 | May 29, 2015 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sagent Pharms Inc | MESNA | mesna | INJECTABLE;INTRAVENOUS | 090913-001 | Apr 13, 2010 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sagent Pharms Inc | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 201835-001 | Jun 27, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sagent Pharms Inc | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 209967-001 | Jan 16, 2020 | AP1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sagent Pharms Inc | METHOTREXATE SODIUM PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 203407-002 | Aug 9, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
